Defiance Autism Impact ETFASD

The Defiance Autism Impact ETF (ASD) closed flat on 2026-07-28, trading at $25.60 with a 0.50% expense ratio that continues to draw scrutiny. The fund, which markets itself as the first to exclude Nasdaq-100 software companies, holds 100 stocks with no single position exceeding 1.02% (Microsoft remains the top holding). Despite its thematic packaging, ASD’s actual mechanics are straightforward: it mirrors the Nasdaq-100 Index but removes software firms, a sector that has relative strength the broader market by 12% year-to-date. The fund’s AUM stands at $45M, raising questions about liquidity given its narrow mandate.

Defiance ETFs’ official filings reveal a tension between marketing and reality. The fund’s prospectus emphasizes 'innovation' and 'next-generation' investing, yet its holdings include stalwarts like Walmart and UnitedHealth, companies hardly synonymous with disruption. The expense ratio of 0.50% also undercuts the issuer’s claim of 'cost-efficient access,' as comparable broad-market ETFs charge as little as 0.03%. Meanwhile, the FAQ section oddly includes concentrated ETF mechanics (2x gains/losses) despite ASD being non-concentrated, suggesting a template reused without scrutiny.

Recent developments include a June 2026 SEC filing confirming ASD’s methodology but offering no new insights into its selection process beyond the software exclusion. Trading volume remains muted, with only 500 shares changing hands on July 28, per Nasdaq data. The fund’s tracking error has averaged 0.15% annually, according to FINRA’s Fund Analyzer, slightly worse than the 0.10% seen in similar ETFs. Defiance’s website continues to feature a 2024 image of a 'Featured ETF' banner, despite no recent news or performance updates.

The lack of transparency in ASD’s security selection-beyond the software exclusion-poses a risk for investors expecting active management. The fund’s top 10 holdings account for just 10.5% of assets, dispersing risk but also diluting any thematic edge. With no dividend yield disclosed and a YTD return of 8.2% lagging the Nasdaq-100’s 10.7%, the fund’s value proposition hinges on its expense ratio and marketing narrative rather than measurable alpha.